Morningstar Awards for Investing Excellence UK 2025: Winners Announced
LONDON–(BUSINESS WIRE)–Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today announced the winners for the 2025... Read more.
Almirall’s 16th Skin Academy Brings Together Leading Experts to Advance Skin Science and Treatment Options in Medical Dermatology
Almirall’s 16th Skin Academy is a unique opportunity for collaboration in medical dermatology as it brings together leading experts from across the globe to advance... Read more.
KBRA Assigns AA+ Rating to County of Buncombe, NC Refunding Limited Obligation Bonds, Series 2025; Affirms AAA Rating for Outstanding GO Bonds and AA+ Rating for Limited Obligation Bonds
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns a long-term rating of AA+ to the County of Buncombe, NC Refunding Limited Obligation... Read more.
FPT and Subaru Accelerate Partnership with a Two-Year Corporate-Level Commitment
HANOI, Vietnam–(BUSINESS WIRE)–$FPT #FPT–FPT Corporation’s automotive subsidiary FPT Automotive and Subaru Corporation Japan recently renewed... Read more.
ZYXI CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Zynex, Inc. Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District... Read more.
Source Capital Declares April and May 2025 Distribution on Common Stock
LOS ANGELES–(BUSINESS WIRE)–The Board of Directors of Source Capital (NYSE: SOR) (the “Fund”), approved maintaining the Fund’s regular monthly... Read more.
Pint Pharma Announces ANVISA’s Approval of BESREMi® (ropeginterferon alfa-2b) for the Treatment of Polycythemia Vera
SÃO PAULO–(BUSINESS WIRE)–Pint Pharma and PharmaEssentia announced today that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® (ropeginterferon... Read more.
Secretome Therapeutics Granted FDA Fast Track Designation for STM-01, a Neonatal Cardiac Progenitor Cell Therapy for HFpEF
DALLAS–(BUSINESS WIRE)–Secretome Therapeutics, a pioneering company in the field of regenerative medicine, today announced that the U.S. Food and Drug... Read more.
Kirby McInerney LLP Reminds Quantum Computing Inc. (QUBT) Investors of Securities Class Action Lawsuit and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–$QUBT #CLASSACTIONLAWSUIT–The law firm of Kirby McInerney LLP reminds investors who purchased Quantum Computing Inc. (“Quantum”... Read more.
If Implements Guidewire InsuranceSuite to Transform Core Systems
COPENHAGEN, Denmark–(BUSINESS WIRE)–Guidewire (NYSE: GWRE) today announced that If Skadeförsäkring (If), the leading property and casualty insurer... Read more.